Immunohistochemical evaluation of p53 expression and proliferative activity in children with Helicobacter pylori associated gastritis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 40, Issue 4, 2005, Pages 467-470

  Ozturk, Yesim ^a   Ozer, Erdener ^a   Lebe, Banu ^a   Bekem, Ozlem ^a   Buyukgebiz, Benal ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Children p53; Gastritis; H. pylori; Intestinal metaplasia; Proliferative activity

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; CELL PROLIFERATION; CHILD; DYSPEPSIA; ENDOSCOPIC BIOPSY; FEMALE; GASTRITIS; GENE MUTATION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR SUPPRESSOR GENE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; KI-67 ANTIGEN; MALE; METAPLASIA; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

HELICOBACTER PYLORI;

EID: 16844386369     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MPG.0000148832.22130.D7     Document Type: Article

References (17)

1. Kikuchi S. Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer 2002;5:6-15.
2. Parsonnet J. H. pylori. Infect Dis Clin North Am 1998;12:185-97.
3. International Agency for Research on Cancer. Evaluation of carcinogenic risks to humans. IARC Monographs 1997;61:1-241.
4. Moss SF. The carcinogenic effect of H. pylori on the gastric epithelial cell. J Physiol Pharmacol 1999;50:847-56.
5. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
6. Chene P. The role of tetramerization in p53 function. Oncogene 2001;20:2611-7.
7. Feng CW, Wang LD, Jiao LH, et al. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2002;2:8.
8. Hibi K, Mitomi H, Koizumi W, et al. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 1997;108:26-34.
9. Jones NL, Shannon PT, Cutz E, et al. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997;151:1695-703.
10. Ozturk Y, Buyukgebiz B, Arslan N, et al. Antral glandular atrophy and intestinal metaplasia in children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 2003;37:96-7.
11. Guarner J, Bartlett J, Whistler T, et al. Can pre-neoplastic lesions be detected in gastric biopsies of children with Helicobacter pylori infection? J Pediatr Gastroenterol Nutr 2003;37:309-14.
12. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: The updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
13. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed parafin sections. J Pathol 1992;168:357-63.
14. Berloco P, Russo F, Cariola F, et al. Low presence of p53 abnormalities in H. pylori-infected gastric mucosa and in gastric adenocarcinoma. J Gastroenterol 2003;38:28-36.
15. Nieder C, Petersen S, Petersen C, et al. The challenge of p53 as prognostic and predictive factor in gliomas. Cancer Treat Rev 2000;26:67-73.
16. Wang DY, Xiang YY, Tanaka M, et al. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 1994;74:3089-96.
17. Shiao YH, Rugge M, Correa P, et al. p53 alteration in gastric precancerous lesions. Am J Pathol 1994;144:511-7.